Corrective effects of original bioflavonoid complex in the cyclophosphamide-induced immunity disorders

Our aim was to evaluate immunomodulatory properties of an original bioflavonoid complex in experimental immune disturbances induced by cyclophosphamide (Cy). We have studied morphometric indexes of thymus and spleen, as well as blood leukocyte counts, cell proliferative activity in lymphoid organs, delayed hypersensitivity responses to T cell-dependent antigen, along with differentiation activity of bone marrow stem cells in experimental animals during Cy-induced immune suppression after a course of bioflavonoid treatment. Suspension of the bioflafonoid complex was introduced to the male mice (СВАхC57Bl/6)F1 aged 12- 14 weeks at a daily dose of 2 mg/animal (80 mg/kg), per os, using gastric catheter, over 14 days. Cytostatic immunosuppression was produced by a single intraperitoneal Cy injection. Proliferative activity of spleen and thymic cells was determined by standard method with Н3 -thymidine incorporation in the 72-h cell culture. Cellular immune response was assayed by the degree of delayed-type hypersensitivity development in response to sheep erythrocytes. The number of hematopoietic progenitors was evaluated by culturing bone marrow cells in methylcellulose-based medium. The experiments have shown mitigation of immunosuppressive effects induced by Cy, in the course of bioflavonoid complex treatment, with respect to absolute and relative mass of lymphoid organs and leukocyte numbers in peripheral blood. Moreover, we have demonstrated decreased effects of Cy treatment upon the spontaneous activity of spleen cells, mitogen-induced thymocyte and splenocyte proliferation, intensivity of delayed-type hypersensitivity response that reached the values of intact animals. Following the course of bioflavonoids, we have revealed an increase in early hematopoietic progenitors. Alleviation of Cy-induced suppressive effects upon cellular immune response, proliferation rates of immune cells, as well as stimulation of hematopoietic stem cell functions suggest a sufficient capacity of the original bioflavonoid complex for modulation of immunity and hematopoiesis, thus presenting experimental proofs for its potential usage as an adjuvant treatment of the patients with malignant diseases.

1. Gaidul K.V., Goldina I.A., Safronova I.V. Investigation of the morphometric parameters of immune system organs at experimental hemosupression under the influence of nutraceutical with epigenome-directed action. Zdorovye i obrazovanie v XXI veke = Health and Education Millenium, 2018, Vol. 20, no. 10, pp. 10-13. (In Russ.)

2. Goldina I.A., Gaidul K.V. Biologica activity and therapeutic properties of Curcuma Longa L. (Review). Vestnik NGU = Bulletin of NSU, 2015, no. 1, pp. 141-149. (In Russ.)

3. Goldina I.A., Markova E.V., Goldin B.G., Knyazheva M.A., Gaidul K.V. The turmeric protective properties at ethanol-induced behavioral disorders. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov Medical Journal, 2017, Vol. 13, no. 1, pp. 131-135. (In Russ.)

4. Lubimov G.Yu., Goldina I.A., Grishina L.V., Gaidul K.V. The influence of Curcuma Longa L. oil extract on the Lewis lung carcinoma growth in the experiment. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2014, Vol. 8 (17), no. 3, pp. 702-704. (In Russ.).

5. Markova E.V., Goldina I.A., Savkin I.V. Bioflavonoids in neuroimmune pathology: mechanisms of action, therapeutic effects. Krasnoyarsk: Research and Innovation Center, 2019. 158 p.

6. Nutriceutical composition / Gaidul K.V., Kornilov S.I. Patent No. 2654868. Inventios and utility models. Official Bullenin of the Intellectual publicity № 15 – 2018, 21.05.2018- 27.05.2018.

7. Safronova I.V., Goldina I.A., Gaidul K.V., Kozlov V.A. Content and pharmacological properties of the biologically active blackberry compounds. Innovatsii i prodovolstvennaya bezopasnost = Innovations and Food Safety, 2017, no. 4 (18), pp. 96-106. (In Russ.)

8. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, Vol. 4, pp. 807-818.

9. Attari F., Zahmatkesh M., Aligholi H., Mehr S.E., Sharifzadeh M., Gorji A., Mokhtari T., Khaksarian M., Hassanzadeh G. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin. Daru, 2015, Vol. 23, no. 1, 33. doi: 10.1186/s40199-015-0115-8.

10. Barilla R.M., Diskin B., Caso R.C., Lee K.B., Mohan N., Buttar C., Adam S., Sekendiz Z., Wang J., Salas R.D., Cassini M.F., Karlen J., Sundberg B., Akbar H., Levchenko D., Gakhal I., Gutierrez J., Wang W., Hundeyin M., Torres-Hernandez A., Leinwand J., Kurz E., Rossi J.A.K., Mishra A., Liria M., Sanchez G., Panta J., Loke P., Aykut B., Miller G. Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma. Nat. Commun., 2019, Vol. 10, no. 1, 1424. doi: 10.1038/s41467-019-09416-2.

11. Berginc K., Trontelj J., Basnet N.S., Kristl A. Physiological barriers to the oral delivery of curcumin. Pharmazie, 2012, Vol. 67, no. 6, pp. 518-524.

12. Bolat Z.B., Islek Z., Demir B.N., Yilmaz E.N., Sahin F., Ucisik M.H. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model. Front. Bioeng. Biotechnol., 2020, Vol. 8, 50. doi: 10.3389/fbioe.2020.00050.

13. Chang L.-C., Yu Y.-L. Dietary components as epigenetic-regulating agent against cancer. BioMedicine, 2016, Vol. 6, pp. 9-16.

14. Chen G., He L., Zhang P., Zhang J., Mei X., Wang D., Zhang Y., Ren X., Chen Z. Encapsulation of green tea polyphenol nanospheres in PVA/alginate hydrogel for promoting wound healing of diabetic rats by regulating PI3K/ AKT pathway. Mater. Sci. Eng. C. Mater. Biol., 2020, Vol. 110, 110686. doi: 10.1016/j.msec.2020.110686.

15. Chen X., Wang J., Fu Z., Zhu B., Wang J., Guan S., Hua Z. Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Sci. Rep., 2017, Vol. 7, no. 1, 17724. doi: 10.1038/s41598-017-16436-9.

16. Ding S., Jiang H., Fang J. Regulation of Immune Function by Polyphenols. J. Immunol. Res., 2018, Vol. 2018, 1264074. doi: 10.1155/2018/1264074.

17. Dion C., Chappuis E., Ripoll C. Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials. Nutr. Metab. (Lond)., 2016, Vol. 13, 28. doi: 10.1186/s12986-016-0086-x.

18. Drapeau C., Benson K.F., Jensen G.S. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clin. Interv. Aging, 2019, Vol. 14, pp. 253-263.

19. Farhana L., Sarkar S., Nangia-Makker P., Yu Y., Khosla P., Levi E., Azmi A., Majumdar A.P.N. Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice. PLoS ONE, 2020, Vol. 15, no. 3, e0229823. doi: 10.1371/journal.pone.0229823.

20. Fu Z., Chen X., Guan S., Yan Y., Lin H., Hua Z.C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget, 2015, Vol. 6, no. 23, pp. 19469-19482.

21. Heebkaew N., Rujanapun N., Kunhorm P., Jaroonwitchawan T., Chaicharoenaudomrung N., Promjantuek W., Noisa P. Curcumin induces neural differentiation of human pluripotent embryonal carcinoma cells through the activation of autophagy. BioMed Res. Int., 2019, 4378710. doi: 10.1155/2019/4378710.

22. Jarosz M., Olbert M., Wyszogrodzka G., Młyniec K., Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 2017, Vol. 25, no. 1, pp. 11-24.

23. Jin N., Lin J., Yang C., Wu C., He J., Chen Z., Yang Q., Chen J., Zheng G., Lv L., Liang H., Chen J., Ruan Z. Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid. Int. J. Pharm., 2020, Vol. 578, 119101. doi: 10.1016/j.ijpharm.2020.119101.

24. Kim M.A., Kim M.J. Isoflavone profiles and antioxidant properties in different parts of soybean sprout. J. Food Sci., 2020, Vol. 85, no. 3, pp. 689-695.

25. Kurbitz C., Heise D., Redmer T., Goumas F., Arlt A., Lemke J., Rimbach G., Kalthoff H., Trauzold A. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and antiinflammatory activities in pancreatic tumor cells. Cancer Sci., 2011, Vol. 102, pp. 728-734.

26. Lewandowska U., Gorlach S., Owczarec K., Hrabec E., Szewczyk K. Synergistic interaction between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postery Hig. Med. Dosw., 2014, Vol. 68. pp. 528-540.

27. Manayi A., Nabavi S.M., Setzer W.N., Jafari S. Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr. Med. Chem., 2018, Vol. 25, no. 37, pp. 4918-4928.

28. Markova E.V., Goldina I.A., Goldin B.G., Knyazheva M.A., Savkin I.V. Turmeric extract in correction of nervous and immune systems functional activity parameters in experimental alcoholism. Мed. Acad. J., 2019, Vol. 19, № S, pp. 215-217.

29. Namiki K., Wongsirisin P., Yokoyama S., Sato M., Rawangkan A., Sakai R., Iida K., Suganuma M. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci. Rep., 2020, Vol. 10, no. 1, 2444. doi: 10.1038/s41598-020-59281-z.

30. Niedzwiecki A., Roomi M.W., Kalinovsky T., Rath M. Anticancer efficacy of polyphenols and their combinations. Nutrients, 2016, Vol. 8, no. 9, 552. doi: 10.3390/nu8090552.

31. Niraula S., Amir E., Vera-Badillo F., Seruga B., Ocana A., Tannock I.F. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J. Clin. Oncol., 2014, Vol. 32, pp. 3634-3642.

32. Pan P., Huang Y.W., Oshima K., Yearsley M., Zhang J., Arnold M., Yu J., Wang L.S. The immunomodulatory potential of natural compounds in tumor-bearing mice and humans. Crit. Rev. Food. Sci. Nutr., 2019, Vol. 59, no. 6, pp. 1-16.

33. Plitas G., Rudensky A.Y. Regulatory T cells: differentiation and function. Cancer Immunol. Res., 2016, Vol. 4, pp. 721-725.

34. Ruffell B., Chang-Strachan D., Chan V., Rosenbusch A., Ho C.M., Pryer N., Daniel D., Hwang E.S., Rugo H.S., Coussens L.M. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell., 2014, Vol. 26, no. 5, pp. 623-637.

35. Sharma A., Shahzad B., Rehman A., Bhardwaj R., Landi M., Zheng B. Response of phenylpropanoid pathway and the role of polyphenols in plants under abiotic stress. Molecules, 2019, Vol. 24, no. 13, 2452. doi: 10.3390/molecules24132452.

36. Snopek L., Mlcek J., Sochorova L., Baron M., Hlavacova I., Jurikova T., Kizek R., Sedlackova E., Sochor J. Contribution of red wine consumption to human health protection. Molecules, 2018, Vol. 23, no. 7, 1684. doi: 10.3390/molecules23071684.

37. Szade K., Gulati G.S., Chan C.K.F., Kao K.S., Miyanishi M., Marjon K.D., Sinha R., George B.M., Chen J.Y., Weissman I.L. Where hematopoietic stem cells live: the Bone marrow niche. Antioxid. Redox Signal., 2018, Vol. 29(2), pp. 191-204.

38. Wu P., Wu D., Zhao L., Huang L., Chen G., Shen G., Huang J., Chai Y. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget, 2016, Vol. 7, pp. 40451-40460.

39. Yang X., Xue Z., Fang Y., Liu X., Yang Y., Shi G., Feng S., Zhao L. Structure-immunomodulatory activity relationships of Hedysarum polysaccharides extracted by a method involving a complex enzyme combined with ultrasonication. J. Food Funct., 2019, Vol. 10, no. 2, pp. 1146-1158.

40. Zhao L.G., Chen T.Q., Feng D.M., Xiao T.G., Dang Z.L., Feng S.L., Xia Y.Y. Structural characterization and antioxidant activity of a heteropolysaccharide isolated from Hedysarum polybotrys. J. Asian Nat. Prod. Res., 2014, Vol. 16(6), pp. 677-684.

41. Zhao Y., Shao Q., Zhu H., Xu H., Long W., Yu B., Zhou L., Xu H., Wu Y., Su Z. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability. Cancer Sci., 2018, Vol. 109, no. 9, pp. 2677-2686.

42. Zou J.Y., Su C.H., Luo H.H., Lei Y.Y., Zeng B., Zhu H.S., Chen Z.G. Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. J. Cell Biochem., 2018, Vol. 119, no. 2, pp. 1420-1428.